
CTOR Technical Analysis Summary (NASDAQ)
Analyze CTOR on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerCTOR Technical Analysis Summary (NASDAQ)
Citius Oncology, Inc. (NASDAQ: CTOR) stock currently shows a bearish trend on the NASDAQ, supported by momentum and weak buying pressure.
Technical conditions suggest Citius Oncology, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that Citius Oncology, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 36.17
Stochastic %K: 18.64
Williams %R: -67.87
Rate of Change (ROC): -24.24
Takeaway:Citius Oncology, Inc. shows weakening momentum, with sellers gaining the edge.
MACD: -0.09
ADX: 41.88
ATR (14): 0.09
CCI (14): -40.39
Takeaway:Citius Oncology, Inc. shows weakening trend signals, with bearish pressure building.
Takeaway:Citius Oncology, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:Citius Oncology, Inc. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:CTOR shows mixed signals in money flow analysis.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Citius Oncology, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.